JW Pharmaceutical Corporation (KRX:001060)

JW Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 8, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	518,108	561,695	828,523	419,688	505,678	753,056
Market Cap Growth	-27.08%	-32.20%	97.41%	-17.00%	-32.85%	22.16%
Enterprise Value	536,310	600,784	959,912	491,395	649,827	873,041
Last Close Price	22550.00	24000.00	34877.84	17456.16	20654.29	30394.81
PE Ratio	10.67	9.24	22.39	13.16	-	-
Forward PE	-	6.50	14.34	10.40	26.79	26.79
PS Ratio	0.70	0.78	1.11	0.61	0.83	1.38
PB Ratio	1.60	1.71	3.12	1.86	2.68	3.63
P/TBV Ratio	1.66	1.76	3.29	1.84	2.68	3.86
P/FCF Ratio	12.29	7.90	13.84	8.96	47.45	14.86
P/OCF Ratio	10.02	7.08	9.51	7.39	27.90	11.94
EV/Sales Ratio	0.72	0.84	1.28	0.72	1.07	1.60
EV/EBITDA Ratio	4.79	5.90	8.05	6.36	13.84	45.08
EV/EBIT Ratio	5.76	7.26	9.93	8.12	21.07	-
EV/FCF Ratio	12.72	8.45	16.03	10.49	60.98	17.23
Debt / Equity Ratio	0.28	0.28	0.64	0.93	1.30	0.88
Debt / EBITDA Ratio	0.82	0.90	1.43	2.71	5.22	9.41
Debt / FCF Ratio	2.15	1.29	2.84	4.47	23.00	3.60
Asset Turnover	1.19	1.15	1.18	1.09	1.03	0.98
Inventory Turnover	3.47	3.64	3.79	3.70	3.65	3.86
Quick Ratio	0.86	0.82	0.90	0.80	0.79	0.78
Current Ratio	1.41	1.47	1.32	1.12	1.30	1.27
Return on Equity (ROE)	17.16%	21.87%	15.65%	14.41%	-0.73%	-6.98%
Return on Assets (ROA)	9.15%	8.28%	9.49%	6.00%	3.26%	-0.15%
Return on Capital (ROIC)	13.55%	12.07%	13.87%	8.70%	4.68%	-0.21%
Return on Capital Employed (ROCE)	25.50%	20.90%	27.00%	24.40%	8.80%	-
Earnings Yield	9.47%	11.58%	4.47%	7.60%	-0.19%	-2.02%
FCF Yield	8.14%	12.65%	7.23%	11.16%	2.11%	6.73%
Dividend Yield	2.00%	1.88%	-	-	-	-
Payout Ratio	21.27%	14.86%	23.82%	23.05%	-	-
Buyback Yield / Dilution	2.44%	2.01%	-2.49%	-0.07%	0.05%	-0.04%
Total Shareholder Return	4.46%	3.89%	-2.49%	-0.07%	0.05%	-0.04%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.